asa guidelines glp 1 A narrative review of glucagon-like peptide-1 receptor agonists prior to deep sedation or general anesthesia American Society of Anesthesiologists Consensus-Based
Description
A new study based on real world data found a possible protective effect against multiple sclerosis for some of new weight loss medications.
bimagrumab) may improve the body composition during WL and are in early phase clinical trials
Background Glucagon-like peptide-1 (GLP-1) induces diuresis and natriuresis
Discover how the GLP-1 revolution with Ozempic and Mounjaro is transforming Type 2 diabetes and obesity treatment, offering new hope and solutions.
Discover how once-monthly maridebart cafraglutide for the treatment of obesity works, its clinical trial evidence, potential eligibility criteria, side effects, and the pathway to NHS access if approved by UK regulators.
Novo Nordisk is putting down up to US$362m to tap into Ascendis TransCon technology for treatments in metabolic and cardiovascular diseases
